Rebecca Berdeaux
Overview
Explore the profile of Rebecca Berdeaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sytsma B, Allain V, Bourke S, Faizee F, Fathi M, Ferreira L, et al.
Sci Rep
. 2025 Feb;
15(1):5749.
PMID: 39962112
Adoptive chimeric antigen receptor T-cell (CAR-T) therapy is transformative and approved for hematologic malignancies. It is also being developed for the treatment of solid tumors, autoimmune disorders, heart disease, and...
2.
Yamaguchi H, Meyer M, Barrell W, Faisal M, Berdeaux R, Liu K, et al.
Differentiation
. 2024 Nov;
142:100818.
PMID: 39500655
Primary cilia (hereafter "cilia") are microtubule-based antenna-like organelles projecting from the surface of vertebrate cells. Cilia can serve as cellular antennae controlling cell growth and differentiation. Absent or dysfunctional cilia...
3.
Sytsma B, Allain V, Bourke S, Faizee F, Fathi M, Berdeaux R, et al.
Res Sq
. 2024 Oct;
PMID: 39372944
Adoptive chimeric antigen receptor T-cell (CAR-T) therapy is transformative and approved for hematologic malignancies. It is also being developed for the treatment of solid tumors, autoimmune disorders, heart disease, and...
4.
Sytsma B, Allain V, Bourke S, Faizee F, Fathi M, Berdeaux R, et al.
bioRxiv
. 2024 Jul;
PMID: 38979201
Adoptive chimeric antigen receptor T-cell (CAR-T) therapy is transformative and approved for hematologic malignancies. It is also being developed for the treatment of solid tumors, autoimmune disorders, heart disease, and...
5.
Bendixen S, Jakobsgaard P, Hansen D, Hejn K, Terkelsen M, Bjerre F, et al.
J Hepatol
. 2023 Nov;
80(3):467-481.
PMID: 37972658
Background & Aims: Metabolic dysfunction-associated steatohepatitis (MASH) is linked to insulin resistance and type 2 diabetes and marked by hepatic inflammation, microvascular dysfunction, and fibrosis, impairing liver function and aggravating...
6.
Wu V, Yung B, Faraji F, Saddawi-Konefka R, Wang Z, Wenzel A, et al.
Nat Immunol
. 2023 Jun;
24(8):1318-1330.
PMID: 37308665
Immune checkpoint blockade (ICB) targeting PD-1 and CTLA-4 has revolutionized cancer treatment. However, many cancers do not respond to ICB, prompting the search for additional strategies to achieve durable responses....
7.
Yoon S, Meyer M, Arevalo C, Tekguc M, Zhang C, Wang J, et al.
J Clin Invest
. 2023 Mar;
133(9).
PMID: 36862513
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown. Here, we demonstrated that salt-inducible kinases (SIKs)...
8.
Li G, Li X, Yang L, Wang S, Dai Y, Fekry B, et al.
Life Sci Alliance
. 2022 Apr;
5(8).
PMID: 35459739
Carboxylesterase 1d (Ces1d) is a crucial enzyme with a wide range of activities in multiple tissues. It has been reported to localize predominantly in ER. Here, we found that Ces1d...
9.
Matsumura S, Miyakita M, Miyamori H, Kyo S, Shima D, Yokokawa T, et al.
Am J Physiol Endocrinol Metab
. 2022 Mar;
322(5):E436-E445.
PMID: 35344393
The melanocortin 4 receptor (MC4R) plays an important role in the regulation of appetite and energy expenditure in humans and rodents. Impairment of MC4R signaling causes severe obesity. MC4R mainly...
10.
Meister J, Bone D, Knudsen J, Barella L, Velenosi T, Akhmedov D, et al.
Nat Commun
. 2022 Jan;
13(1):22.
PMID: 35013148
Activation of the sympathetic nervous system causes pronounced metabolic changes that are mediated by multiple adrenergic receptor subtypes. Systemic treatment with βadrenergic receptor agonists results in multiple beneficial metabolic effects,...